Zebra Technologies (ZBRA) encountered a series of ups and downs recently. CEO's 2025 pay details emerged simultaneously with a 'Moderate Buy' consensus from analysts, reflecting a strong growth potential despite the company's removal from the FTSE All-World Index. While ZBRA reports a $1.5 billion Q4 net sales with a growth of 10.6%, its share price performance has been weak, leading analysts to reassess ZBRA's valuation. However, several shareholders such as Exchange Traded Concepts and Moore Capital Management have increased their stake while others reduced their positions. The company is striving to boost its market position through a strong partner network and innovative pushes like Orchestrated Care for hospitals. Despite the recent challenges such as its share price plummeting, hitting a new 52-week low, potentially due to the reduction in the price target by some analysts, it's suggested that this could create a potential valuation opportunity. The number of investors buying into the stock has been on the rise as holdings increase despite some uncertainty due to geopolitical events and internal realignments.
Zebra Technologies Stocks ZBRA News Analytics from Tue, 05 Aug 2025 07:00:00 GMT to Sat, 04 Apr 2026 21:26:00 GMT -
Rating 2
- Innovation 5
- Information 8
- Rumor 5
